MARKET INTRODUCTION

Oncolytic virus is a type of immunotherapy that uses viruses to infection and destruction of cancer cells. Infection by certain viruses has been implicated in the development of certain cancers. Recently, viruses have been used to attack and target tumor cells that are already formed in the human body. The new therapy presents promising approach in the treatment of various types of cancers.

MARKET DYNAMICS

The oncolytic virus immunotherapy market is driving due to the factors such as support from FDA and other regulatory authorities to ramp-up the research procedures and capabilities for development of viral therapies and increasing prevalence of cancer patients across the globe. In addition, development and launch of new and innovative biotechnology based therapies are likely to offer growth opportunities for market players.

MARKET SCOPE

The "Oncolytic Virus Immunotherapy Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of oncolytic virus immunotherapy market with detailed market segmentation by type and end user. The oncolytic virus immunotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in oncolytic virus immunotherapy market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The oncolytic virus immunotherapy market is segmented on the basis of virus type, route of administration and application. Based on virus type, the market is segmented as herpes simplex virus, vaccinia virus, adenovirus, reovirus, and others. On the basis of route of administration, the market is segmented into intratumoral and intravenous. Based on application, the market is segmented into melanoma, non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the oncolytic virus immunotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncolytic virus immunotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oncolytic virus immunotherapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the oncolytic virus immunotherapy market in these regions.

MARKET PLAYERS

The report covers key developments in the oncolytic virus immunotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from oncolytic virus immunotherapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for oncolytic virus immunotherapy in the global market. Below mentioned is the list of few companies engaged in the oncolytic virus immunotherapy market.

The report also includes the profiles of key players in oncolytic virus immunotherapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

- Amgen, Inc.
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- TILT Biotherapeutics
- Oncorus, Inc.
- Oncolys BioPharma, Inc.
- Sorrento Therapeutics, Inc.
- Oncolytics Biotech, Inc.
- SillaJen, Inc.
- Replimune Group